Bone marrow-derived mononuclear cells therapy for ischemic stroke
Background: Nowadays, the cerebrovascular event is the second cause of death and the third cause of disability worldwide. In the last few decades, stem cell-based approaches are widely analyzed as a potential treatment for this disease. One of these types of cells are bone marrow-derived mononuclea...
Main Authors: | Petru Butucel, Viorel Nacu, Vitalie Lisnic |
---|---|
Format: | Article |
Language: | English |
Published: |
Scientific Medical Association of Moldova
2019-12-01
|
Series: | The Moldovan Medical Journal |
Subjects: | |
Online Access: | http://moldmedjournal.md/wp-content/uploads/2019/12/moldovan-med-j-2019-62-4-butucel-et-al-full-text.pdf |
Similar Items
-
Paracrine Mechanisms of Intravenous Bone Marrow-Derived Mononuclear Stem Cells in Chronic Ischemic Stroke
by: Ashu Bhasin, et al.
Published: (2016-10-01) -
Serial Cerebral Metabolic Changes in Patients With Ischemic Stroke Treated With Autologous Bone Marrow Derived Mononuclear Cells
by: Muhammad E. Haque, et al.
Published: (2019-02-01) -
Intravenous Bone Marrow Mononuclear Cells Transplantation Improves the Effect of Training in Chronic Stroke Mice
by: Yuko Ogawa, et al.
Published: (2020-11-01) -
Autologous bone marrow-derived mononuclear cell therapy in three patients with severe asthma
by: Fabio S. Aguiar, et al.
Published: (2020-05-01) -
THERAPEUTIC ANGIOGENESIS BY GROWTH FACTORS AND BONE MARROW MONONUCLEAR CELLS ADMINISTRATION: BIOLOGICAL FOUNDATION AND CLINICAL PROSPECTS
by: D. V. Bulgin, et al.
Published: (2015-10-01)